| Cat. # | Size | Qty. | Price |
|---|---|---|---|
| 8579T | 1 Kit (9 x 20 microliters) |
|
| Product Includes | Quantity | Applications | Reactivity | MW(kDa) | Isotype |
|---|---|---|---|---|---|
| Phospho-YAP (Ser397) (D1E7Y) Rabbit mAb 13619 | 20 µl |
|
H M R | 65-78 | Rabbit IgG |
| LATS1 (C66B5) Rabbit mAb 3477 | 20 µl |
|
H M Mk | 140 | Rabbit IgG |
| Phospho-MOB1 (Thr35) (D2F10) Rabbit mAb 8699 | 20 µl |
|
H M R Mk | 24 | Rabbit IgG |
| MOB1 (E1N9D) Rabbit mAb 13730 | 20 µl |
|
H M R Hm Mk | 24 | Rabbit IgG |
| MST1 Antibody 3682 | 20 µl |
|
H M R Mk B | 59 | Rabbit |
| MST2 Antibody 3952 | 20 µl |
|
H M R Mk B | 60 | Rabbit |
| SAV1 (D6M6X) Rabbit mAb 13301 | 20 µl |
|
H M | 45 | Rabbit IgG |
| Phospho-YAP (Ser127) (D9W2I) Rabbit mAb 13008 | 20 µl |
|
H M R | 65-78 | Rabbit IgG |
| YAP/TAZ (D24E4) Rabbit mAb 8418 | 20 µl |
|
H M Mk | 55, 78 | Rabbit IgG |
| Anti-rabbit IgG, HRP-linked Antibody 7074 | 100 µl |
|
Goat |
Product Information
Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to residues near the amino terminus of human Mst1 protein, or residues near the amino terminus of human Mst2 protein. Polyclonal antibodies are purified by protein A and peptide affinity chromatography. Monoclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to residues near the amino terminus of human MOB1A protein, residues surrounding Gly180 of human LATS1 protein, residues near the carboxy terminus of human SAV1 protein, or residues surrounding Asp362 of human TAZ protein. Phospho-specific monoclonal antibodies are produced by immunizing animals with a synthetic phosphopeptide corresponding to residues surrounding Thr35 of human MOB1 protein, residues surrounding Ser397 of human YAP protein isoform 1, or residues surrounding Ser127 of human YAP protein.
Hippo signaling is an evolutionarily conserved pathway that controls cell proliferation, apoptosis, and organ size in response to changing cell density levels (1,2). At relative low cell density, transcription co-activators YAP and TAZ bind transcription factors to induce expression of genes that favor cell growth and proliferation. As cell density increases, interaction between membrane-bound upstream hippo pathway regulators trigger activation of cytoplasmic kinases Mst1/2 and LATS1/2. Activated Mst kinase (the eponymous Hippo in Drosophila) associates with the adaptor Sav1 and phosphorylates MOB1 to activate LATS kinase, which phosphorylates YAP and TAZ to suppress cell proliferation (3).
Except as otherwise expressly agreed in a writing signed by a legally authorized representative of CST, the following terms apply to Products provided by CST, its affiliates or its distributors. Any Customer's terms and conditions that are in addition to, or different from, those contained herein, unless separately accepted in writing by a legally authorized representative of CST, are rejected and are of no force or effect.
Products are labeled with For Research Use Only or a similar labeling statement and have not been approved, cleared, or licensed by the FDA or other regulatory foreign or domestic entity, for any purpose. Customer shall not use any Product for any diagnostic or therapeutic purpose, or otherwise in any manner that conflicts with its labeling statement. Products sold or licensed by CST are provided for Customer as the end-user and solely for research and development uses. Any use of Product for diagnostic, prophylactic or therapeutic purposes, or any purchase of Product for resale (alone or as a component) or other commercial purpose, requires a separate license from CST. Customer shall (a) not sell, license, loan, donate or otherwise transfer or make available any Product to any third party, whether alone or in combination with other materials, or use the Products to manufacture any commercial products, (b) not copy, modify, reverse engineer, decompile, disassemble or otherwise attempt to discover the underlying structure or technology of the Products, or use the Products for the purpose of developing any products or services that would compete with CST products or services, (c) not alter or remove from the Products any trademarks, trade names, logos, patent or copyright notices or markings, (d) use the Products solely in accordance with CST Product Terms of Sale and any applicable documentation, and (e) comply with any license, terms of service or similar agreement with respect to any third party products or services used by Customer in connection with the Products.
